Search Results
Jul 14, 2026, 19:30 ET Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
[1] MSD is the tradename of Merck & Co., Inc, Rahway, NJ, USA.[2] KEYTRUDA® (pembrolizumab) is a registered trademark of Merck Sharp & Dohme LLC (MSD), a subsidiary
More news about: Kelun-Biotech
Jul 08, 2026, 20:00 ET Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
differentiated small-molecule therapies, and providing superior oral alternatives to biologics. The company was founded by senior R&D leaders from Pfizer, MSD, and Johnson & Johnson, focusing on the JAK-STAT and expanding to TYK2 signaling pathways, and mastering targeted protein degradation.The
More news about: Lynk Pharmaceuticals Co., Ltd.
Jul 01, 2026, 09:00 ET Forward AI Wins Two Cybersecurity Awards for Bringing Certainty to Agentic AI
customer experiences $14.2M in annual benefits through improved efficiency and security.Backed by A. Capital, Andreessen Horowitz, Goldman Sachs, MSD Partners, Omega Venture Partners, Section 32, and Threshold Ventures, Forward is headquartered in Santa Clara, California. For more information, visit
More news about: Forward Networks, Inc.
Jul 01, 2026, 09:00 ET Forward AI Wins Two Cybersecurity Awards for Bringing Certainty to Agentic AI
customer experiences $14.2M in annual benefits through improved efficiency and security.Backed by A. Capital, Andreessen Horowitz, Goldman Sachs, MSD Partners, Omega Venture Partners, Section 32, and Threshold Ventures, Forward is headquartered in Santa Clara, California. For more information, visit
More news about: Forward Networks, Inc.
Jun 30, 2026, 23:10 ET AAHRPP Accredits Five More Research Entities
MedStar Health Research Institute, Columbia, MDMerck & Co., Inc., Merck Research Laboratories, Global Clinical DevelopmentMSD Korea Co., Ltd., Global Clinical Trial OperationsTriHealth Inc., Cincinnati, OHUniformed Services University of the Health Sciences,
More news about: Association for the Accreditation of Human Research Protection Programs
Jun 29, 2026, 16:30 ET Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor
chief executive officer, VylorJohannes "Jannie" J. Oosthuizen, executive vice president and president, oncology and MSD International, Merck & Co., Inc.Kerry Preete, retired executive vice president and chief strategy officer, Monsanto
More news about: Corteva Agriscience
Jun 24, 2026, 15:45 ET Abu Dhabi gibt Partnerschaft mit MSD bekannt, um die operative Exzellenz zu fördern und den Zugang in der gesamten Region zu erweitern
Durch diese Allianz erhält MSD direkten Zugang zu einem gut vernetzten, hochmodernen Vertriebsnetzwerk und festigt damit die Rolle des Emirats als sicherer regionaler Einführungsmarkt für medizinische Lösungen der nächsten Generation.Ashraf Mallak, Geschäftsführer von MSD für die Golfstaaten, Libyen
More news about: The Department of Health - Abu Dhabi
Jun 24, 2026, 15:41 ET Abu Dhabi annonce un partenariat avec MSD pour renforcer l'excellence opérationnelle et élargir l'accès aux soins dans toute la région
partenariat, MSD bénéficie d'un accès direct à un écosystème de distribution de pointe et très maillé, consolidant ainsi le rôle de l'émirat en tant que marché régional de lancement sûr pour les solutions médicales de nouvelle génération.Ashraf Mallak, directeur général de MSD pour les pays
More news about: The Department of Health - Abu Dhabi
Jun 24, 2026, 15:11 ET Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
vulnerabilities. Through this alliance, MSD gains direct access to a highly connected, advanced distribution ecosystem, cementing the emirate's role as a secure, regional launch market for next-generation medical solutions.Ashraf Mallak, Managing Director MSD Gulf Countries, Libya and Egypt, said:
More news about: The Department of Health - Abu Dhabi
Jun 24, 2026, 15:05 ET Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
vulnerabilities. Through this alliance, MSD gains direct access to a highly connected, advanced distribution ecosystem, cementing the emirate's role as a secure, regional launch market for next-generation medical solutions.Ashraf Mallak, Managing Director MSD Gulf Countries, Libya and Egypt, said:
More news about: The Department of Health - Abu Dhabi
Jun 22, 2026, 15:30 ET ANVISA aprova nova opção de imunoterapia subcutânea da MSD para diversos tipos de câncer
aprovou uma nova forma de aplicação de pembrolizumabe, chamada de KEYTRUDA SCTM (pembrolizumabe e berahialuronidase alfa-pmph), medicamento da MSD indicado para o tratamento de diversos tipos de câncer. Diferentemente da versão tradicional, aplicada via intravenosa, o medicamento agora pode ser
More news about: MSD
Jun 22, 2026, 14:14 ET Phanes Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of Spevatamig in Combination with Chemotherapy for the Frontline Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
metastatic claudin 18.2-positive pancreatic adenocarcinoma in 2024. In 2023, Phanes entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada) to study spevatamig in combination with pembrolizumab.Phanes is conducting clinical trials with spevatamig in multiple
More news about: Phanes Therapeutics, Inc.
Jun 22, 2026, 01:45 ET Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell
registrational clinical studies in China. MSD is evaluating 17 ongoing global Phase III clinical studies of sac-TMT as a monotherapy or in combination with pembrolizumab or other anti-cancer agents for several types of cancer. These studies are sponsored and led by MSD.About Kelun-BiotechKelun-Biotech
More news about: Kelun-Biotech
Jun 17, 2026, 11:30 ET Cystic Fibrosis: Merck Manuals Shares What Patients and Parents Need to Know
MerckManuals.com.About The Merck Manuals and MSD ManualsFirst published in 1899 as a pocket-sized reference for physicians and pharmacists, The Merck Manual has evolved into one of the world's
More news about: The Merck Manuals
Jun 17, 2026, 08:01 ET Nectin Therapeutics Reports Encouraging Phase 1 Results for NTX1088 in Combination with Keytruda® (pembrolizumab) at ASCO 2026
today announced the presentation of Phase 1a/1b clinical data of NTX1088 in combination with pembrolizumab (Keytruda®), Merck's (known as MSD outside of the U.S. and Canada) anti-PD1 therapy, during an oral presentation at the 2026 annual meeting of the American Society of Clinical Oncology
More news about: Nectin Therapeutics, LTD.
Jun 16, 2026, 08:02 ET Nivi, Inc. and MSD Collaborate to Expand HPV Disease Awareness and Cervical Cancer Prevention Through AI-Powered Platform
June 16, 2026 /PRNewswire/ -- Nivi, Inc., a digital health innovator specializing in personalized healthcare guidance and consumer insights, and MSD (known as Merck Sharp & Dohme LLC in the United States and Canada, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA) today announced a global
More news about: Nivi, Inc.
Jun 15, 2026, 09:00 ET Forward Named 2026 Fortune Best Workplaces in the Bay Area for Third Consecutive Year
experiences $14.2M in annual benefits through improved efficiency and security.Backed by A. Capital, Andreessen Horowitz, Goldman Sachs, MSD Partners, Omega Venture Partners, Section 32, and Threshold Ventures, Forward is headquartered in Santa Clara, California. For more information, visit
More news about: Forward Networks, Inc.
Jun 15, 2026, 09:00 ET Forward Named 2026 Fortune Best Workplaces in the Bay Area for Third Consecutive Year
experiences $14.2M in annual benefits through improved efficiency and security.Backed by A. Capital, Andreessen Horowitz, Goldman Sachs, MSD Partners, Omega Venture Partners, Section 32, and Threshold Ventures, Forward is headquartered in Santa Clara, California. For more information, visit
More news about: Forward Networks, Inc.
Jun 09, 2026, 16:05 ET The CRE Finance Council Announces New Chairs for Industry Forums
welcomes Tony LaBarbera (Blackstone) as Chair-Elect, Rachel Hunter-Goldman (KKR - Kohlberg Kravis Roberts) as Chair, and Samantha Rotchford (BDT & MSD Partners) as Past-Chair. In 2025-2026, Samir Tejpaul (Madison Realty Capital) served as Past-Chair.B-Piece Investors.
More news about: CRE Finance Council
Jun 09, 2026, 09:39 ET Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
differentiated small-molecule therapies, and providing superior oral alternatives to biologics. The company was founded by senior R&D leaders from Pfizer, MSD, and Johnson & Johnson, focusing on the JAK-STAT and expanding to TYK2 signaling pathways, and mastering targeted protein degradation.The
More news about: Lynk Pharmaceuticals Co., Ltd.
Jun 09, 2026, 09:00 ET Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor
differentiated small-molecule therapies, and providing superior oral alternatives to biologics. The company was founded by senior R&D leaders from Pfizer, MSD, and Johnson & Johnson, focusing on the JAK-STAT and expanding to TYK2 signaling pathways, and mastering targeted protein degradation.This
More news about: Formation Bio
Jun 09, 2026, 09:00 ET Oryx Dental Software and the Academy of General Dentistry (AGD) Partner to Advance the Future of AI-Powered Dental Excellence
our industry. For most patients, a general dentist is their first trusted stop for tooth pain and other oral health concerns," said Rania Saleh, DDS, MSD, Founder and CEO of Oryx. "Our platform is ideally designed for these powerhouses of the dental profession, offering robust clinical and business management
More news about: Oryx Dental
Jun 05, 2026, 04:54 ET Le Sommet Veeva présente Falcon et l'avenir de la biopharmacie agentique
Plus de 2 000 personnes se sont réunies pour découvrir l'avenir de l'IA dans l'industrie AOP Health, Boehringer Ingelheim, GSK, Haleon, MSD, Novo Nordisk, Roche, Sanofi et Sobi figurent parmi les leaders qui partagent leurs stratégies afin de rationaliser et connecter leurs opérations
More news about: Veeva Systems
Jun 04, 2026, 16:59 ET Veeva Summit gibt einen Ausblick auf Falcon und den Weg zu einer agentenbasierten Biopharma-Branche
versammelten sich, um einen Einblick in die Zukunft der KI in der Industrie zu erhalten AOP Health, Boehringer Ingelheim, GSK, Haleon, MSD, Novo Nordisk, Roche, Sanofi und Sobi gehören zu den führenden Unternehmen, die Strategien zur Rationalisierung und Vernetzung ihrer Betriebsabläufe
More news about: Veeva Systems
Jun 04, 2026, 05:52 ET La Cumbre de Veeva presenta Falcon y el camino hacia la biofarmacia con agentes
2.000 personas se reunieron para conocer el futuro de la IA en la industria.AOP Health, Boehringer Ingelheim, GSK, Haleon, MSD, Novo Nordisk, Roche, Sanofi y Sobi, entre otros líderes, compartieron estrategias para optimizar y conectar sus operaciones.BARCELONA,
More news about: Veeva Systems